Skip to product information
1 of 1

BT Lab

SKU:BT-MCA0857

Lyn Monoclonal Antibody

Lyn Monoclonal Antibody

Regular price $300.00 USD
Regular price Sale price $300.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Host
Ab type

This gene encodes a tyrosine protein kinase, which maybe involved in the regulation of mast cell degranulation, and erythroid differentiation. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Introducing the LYN Monoclonal Antibody, a cutting-edge pharmaceutical innovation designed to revolutionize the field of immunotherapy. This meticulously engineered therapeutic agent harnesses the power of monoclonal antibodies to target and neutralize the LYN protein, a key player in various cellular signaling pathways implicated in numerous diseases.

The LYN Monoclonal Antibody boasts exceptional specificity and affinity, ensuring precise and potent binding to the LYN protein. Through this highly targeted approach, it effectively inhibits aberrant signaling cascades associated with pathological conditions, thereby offering a promising avenue for therapeutic intervention.

With its advanced formulation, the LYN Monoclonal Antibody exhibits remarkable stability and bioavailability, facilitating optimal pharmacokinetics and enhancing patient compliance. Its well-characterized safety profile further underscores its potential as a reliable and well-tolerated treatment option.

The LYN Monoclonal Antibody holds immense therapeutic potential across a wide range of indications, including but not limited to oncology, autoimmune disorders, and inflammatory diseases. Its versatility and adaptability make it an invaluable tool for clinicians and researchers alike, enabling them to explore novel treatment modalities and expand the frontiers of medical science.

In summary, the LYN Monoclonal Antibody represents a groundbreaking advancement in the realm of immunotherapy. With its unrivaled specificity, stability, and therapeutic potential, it stands poised to revolutionize the landscape of disease management and improve patient outcomes. Embrace the future of medicine with the LYN Monoclonal Antibody and unlock a world of possibilities in the pursuit of optimal health and well-being.

View full details